Cover Image

PAPERBACK
$15.00



View/Hide Left Panel

Appendix A
References

Brookmeyer, R., E. Johnson, K. Ziegler-Graham, and H. M. Arrighi. 2007. Forecasting the global burden of Alzheimer’s disease. Alzheimer’s and Dementia 3(3):186–191.

Burns, L., G. L’Italien, Z. Guo, P. Lapuerta, R. M. Berman, S. Kaplita, H. Feldman, M. Donohue. 2010. Exploring CSF biomarker cutpoints with penalized spline analysis and maximized log rank test. Alzheimer’s and Dementia 6(4):S508.

Dubois, B., H. H. Feldman, C. Jacova, S. T. Dekosky, P. Barberger-Gateau, J. Cummings, A. Delacourte, D. Galasko, S. Gauthier, G. Jicha, K. Meguro, J. O’Brien, F. Pasquier, P. Robert, M. Rossor, S. Salloway, Y. Stern, P. J. Visser, and P. Scheltens. 2007. Research criteria for the diagnosis of Alzheimer’s disease: Revising the NINCDS-ADRDA criteria. Lancet Neurol 6(8):734–746.

Ellis, K. A., A. I. Bush, D. Darby, D. De Fazio, J. Foster, P. Hudson, N. T. Lautenschlager, N. Lenzo, R. N. Martins, P. Maruff, C. Masters, A. Milner, K. Pike, C. Rowe, G. Savage, C. Szoeke, K. Taddei, V. Villemagne, M. Woodward, and D. Ames. 2009. The Australian Imaging, Biomarkers and Lifestyle (AIBL) Study of Aging: Methodology and baseline characteristics of 1,112 individuals recruited for a longitudinal study of Alzheimer’s disease. Int Psychogeriatr 21(4):672–687.

Frisoni, G. B., N. C. Fox , C. R. Jack, Jr., P. Scheltens, and P. M. Thompson. 2010. The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol 6(2):67–77.

Jack, C. R., Jr., D. S. Knopman, W. J. Jagust, L. M. Shaw, P. S. Aisen, M. W. Weiner, R. C. Petersen, and J. Q. Trojanowski. 2010. Hypothetical model of dynamic biomarkers of the Alzheimer’s pathological cascade. Lancet Neurol 9(1):119–128.

Rowe, C. C., K. A. Ellis, M. Rimajova, P. Bourgeat, K. E. Pike, G. Jones, J. Fripp, H. Tochon-Danguy, L. Morandeau, G. O’Keefe, R. Price, P. Raniga, P. Robins, O. Acosta, N. Lenzo, C. Szoeke, O. Salvado, R. Head, R. Martins, C. L. Masters, D. Ames, and V. L. Villemagne. 2010. Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) Study of Aging. Neurobiol Aging 31(8):1275–1283.

United Nations. 2007. World population prospects: The 2006 revision, highlights. Working Paper No. ESA/P/WP.202. Department of Economic and Social Affairs, Population Division.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 19
Appendix A References Brookmeyer, R., E. Johnson, K. Ziegler-Graham, and H. M. Arrighi. 2007. Forecasting the global burden of Alzheimer’s disease. Alzheimer’s and Dementia 3(3):186–191. Burns, L., G. L’Italien, Z. Guo, P. Lapuerta, R. M. Berman, S. Kaplita, H. Feldman, M. Donohue. 2010. Exploring CSF biomarker cutpoints with penalized spline analysis and maximized log rank test. Alzheimer’s and Dementia 6(4):S508. Dubois, B., H. H. Feldman, C. Jacova, S. T. Dekosky, P. Barberger-Gateau, J. Cummings, A. Delacourte, D. Galasko, S. Gauthier, G. Jicha, K. Meguro, J. O’Brien, F. Pasquier, P. Robert, M. Rossor, S. Salloway, �. Stern, P. J. Visser, and P. Scheltens. 2007. Research criteria for the diagnosis of Alzheimer’s disease: Revising the NINCDS-ADRDA criteria. Lancet Neurol 6(8):734–746. Ellis, K. A., A. I. Bush, D. Darby, D. De Fazio, J. Foster, P. Hudson, N. T. Lautenschlager, N. Lenzo, R. N. Martins, P. Maruff, C. Masters, A. Milner, K. Pike, C. Rowe, G. Savage, C. Szoeke, K. Taddei, V. Villemagne, M. Woodward, and D. Ames. 2009. The Australian Imaging, Biomarkers and Lifestyle (AIBL) Study of Aging: Methodology and baseline characteristics of 1,112 individuals recruited for a longitudinal study of Alzheimer’s disease. Int Psychogeriatr 21(4):672–687. Frisoni, G. B., N. C. Fox , C. R. Jack, Jr., P. Scheltens, and P. M. Thompson. 2010. The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol 6(2):67–77. Jack, C. R., Jr., D. S. Knopman, W. J. Jagust, L. M. Shaw, P. S. Aisen, M. W. Weiner, R. C. Petersen, and J. Q. Trojanowski. 2010. Hypothetical model of dynamic biomarkers of the Alzheimer’s pathological cascade. Lancet Neurol 9(1):119–128. Rowe, C. C., K. A. Ellis, M. Rimajova, P. Bourgeat, K. E. Pike, G. Jones, J. Fripp, H. Tochon- Danguy, L. Morandeau, G. O’Keefe, R. Price, P. Raniga, P. Robins, O. Acosta, N. Lenzo, C. Szoeke, O. Salvado, R. Head, R. Martins, C. L. Masters, D. Ames, and V. L. Villemagne. 2010. Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) Study of Aging. Neurobiol Aging 31(8):1275–1283. United Nations. 2007. World population prospects: The 00 revision, highlights. Work- ing Paper No. ESA/P/WP.202. Department of Economic and Social Affairs, Population Division. 

OCR for page 19